A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer by Jhaveri, Komal, Chandarlapaty, Sarat, Lake, Diana, Gilewski, Teresa, Robson, Mark, Goldfarb, Shari, Drullinsky, Pamela, Sugarman, Steven, Wasserheit-Leiblich, Carolyn, Fasano, Julie, Moynahan, Mary Ellen, D'Andrea, Gabriella, Lim, Kristina, Reddington, Laura, Haque, Sofia, Patil, Sujata, Bauman, Lynne, Vukovic, Vojo, El-Hariry, Iman, Hudis, Clifford, Modi, Shanu

Get full text